Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway

International Journal of Gynecological Cancer

Volumn 22, Issue 2, 2012, Pages 226-231

  Aune, Guro ^a   Torp, Sverre H ^b   Syversen, Unni ^a,b   Hagen, Bjørn ^b   Tingulstad, Solveig ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Centralized surgery; Hospital level; Ovarian cancer; Reoperation

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HEALTH SERVICE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NORWAY; OVARY CANCER; PERITONEUM CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; TEACHING HOSPITAL; TREATMENT OUTCOME; UTERINE TUBE TUMOR;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NORWAY; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WOMEN'S HEALTH;

EID: 84858272047     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31823589ef     Document Type: Article

References (25)

1. Stitzenberg KB, Meropol NJ. Trends in centralization of cancer surgery. Ann Surg Oncol. 2010;17:2824-2831.
2. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-1137. (Pubitemid 34984604)
3. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747-1751. (Pubitemid 28536874)
4. Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol. 2003;102:499-505. (Pubitemid 37311211)
5. Junor EJ, Hole DJ, McNulty L, et al. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 1999;106:1130-1136. (Pubitemid 29495411)
6. Eisenkop SM, Spirtos NM, Montag TW, et al. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47:203-209. (Pubitemid 23001329)
7. Paulsen T, Kjaerheim K, Kaern J, et al. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer. 2006;16(suppl 1):11-17.
8. Giede KC, Kieser K, Dodge J, et al. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol. 2005;99:447-461. (Pubitemid 41502860)
9. Grossi M, Quinn MA, Thursfield VJ, et al. Ovarian cancer: patterns of care in Victoria during 1993-1995. Med J Aust. 2002;177:11-16. (Pubitemid 34763854)
10. Puls LE, Carrasco R, Morrow MS, et al. Stage I ovarian carcinoma: specialty-related differences in survival and management. South Med J. 1997;90:1097-1100. (Pubitemid 27518188)
11. Vernooij F, Heintz P, Witteveen E, et al. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol. 2007;105:801-812. (Pubitemid 46734206)
12. Elit L, Bondy SJ, Paszat L, et al. Outcomes in surgery for ovarian cancer. Gynecol Oncol. 2002;87:260-267. (Pubitemid 36034645)
13. Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97:922-929. (Pubitemid 20340625)
14. Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol. 1999;93: 448-452. (Pubitemid 29107011)
15. Andersen ES, Knudsen A, Rix P, et al. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol. 2003;90:109-112. (Pubitemid 37338084)
16. Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: International Agency for Research on Cancer; 2003.
17. Verleye L, Vergote I, van der Zee AG. Patterns of care in surgery for ovarian cancer in Europe. Eur J Surg Oncol. 2010;36(suppl 1):S108-S114.
18. Vernooij F, Heintz AP, Witteveen PO, et al. Specialized care and survival of ovarian cancer patients in the Netherlands: nationwide cohort study. J Natl Cancer Inst. 2008;100:399-406. (Pubitemid 351480512)
19. Munstedt K, von Georgi R, Misselwitz B, et al. Centralizing surgery for gynecologic oncology - a strategy assuring better quality treatment? Gynecol Oncol. 2003;89:4-8. (Pubitemid 36403641)
20. Grabowski JP, Harter P, Buhrmann C, et al. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery. Surg Oncol. 2010 Sep 27. [Epub ahead of print].
21. Le T, Adolph A, Krepart GV, et al. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol. 2002;85:351-355. (Pubitemid 34522997)
22. Kommoss S, Harter P, Traut A, et al. Compliance to consensus recommendations, surgeon's experience, and introduction of a quality assurance and management program: influence on therapy of early-stage ovarian carcinoma. Int J Gynecol Cancer. 2009;19:787-793.
23. Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072-3076. (Pubitemid 14201622)
24. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009;45:931-991.
25. Colombo N, Van Gorp T, Parma G, et al. Ovarian cancer. Crit Rev Oncol Hematol. 2006;60:159-179. (Pubitemid 44636248)